ADVANCED COLORECTAL ADENOCARCINOMA
Clinical trials for ADVANCED COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Hard-to-Treat colorectal cancer
Disease control OngoingThis study tests a combination of three drugs (botensilimab, balstilimab, and regorafenib) in people with a type of advanced colorectal cancer that has not responded to prior chemotherapy. The goal is to see if this mix can shrink tumors or slow the cancer's growth. About 28 adul…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 05:46 UTC
-
New hope for Tough-to-Treat colorectal cancer? drug combo trial underway
Disease control TerminatedThis study is for people with advanced colorectal cancer that has a specific genetic change called a KRAS mutation, and whose cancer has worsened after standard treatments. The goal is to test the safety of combining two drugs, AVUTOMETINIB and cetuximab, and find the best dose. …
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 15, 2026 11:56 UTC